CAR-T Meeting 2022 | The use of CAR-T cell products in a real-world setting
Eleni Gavriilaki
• 8 Feb 2022
In this video, Eleni Gavriilaki, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece, discusses a presentation which highlights some results showing the efficacy and minimal toxicity of chimeric antigen receptor T-cell (CAR-T) products in a real-world setting, and how these findings may help to improve patient outcomes in the future. This interview took place at the EBMT-EHA 4th European CAR T-cell Meeting which was held virtually in 2022.
Disclosures
Dr Gavriilaki has served as a consultant and/or received honoraria from Alexion Pharmaceuticals, Omeros Corporation, and Sanofi.
Dr Gavriilaki has received research support from Jazz Pharmaceuticals.
